Literature DB >> 1276090

A proportional study of cancer registrations of dockyard workers.

K P Lumley.   

Abstract

Evidence of an occupational effect due to asbestos exposure was sought by comparing cancer registrations for dockyard workers with those for Plymouth men in the same age groups for 1960-69. The results show a significant excess of pleural tumours in the dockyard group but no significant excesses at other sites. Registrations for pleural mesothelioma were recorded for men with many dockyard occupations and the observed mean interval between first exposure to asbestos and registration for a pleural tumour (37.6 years) indicates that cases of pleural mesothelioma may be expected to occur among these workers for many years, even though crocidolite is no longer used in naval ships. A trend of increasing annual excess of stomach and gastrointestinal registrations was observed in the dockyard group. No cases of peritoneal mesothelioma were recorded but it is likely that some did occur which were diagnosed as cancers arising from other sites. This may account for some of the excess of gastrointestinal registrations.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1276090      PMCID: PMC1008114          DOI: 10.1136/oem.33.2.108

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  18 in total

1.  ASBESTOS EXPOSURE AND NEOPLASIA.

Authors:  I J SELIKOFF; J CHURG; E C HAMMOND
Journal:  JAMA       Date:  1964-04-06       Impact factor: 56.272

2.  Mortality from lung cancer in asbestos workers.

Authors:  R DOLL
Journal:  Br J Ind Med       Date:  1955-04

3.  Asbestos and laryngeal carcinoma.

Authors:  P M Stell; T McGill
Journal:  Lancet       Date:  1973-08-25       Impact factor: 79.321

4.  Asbestos exposure, smoking, and neoplasia.

Authors:  I J Selikoff; E C Hammond; J Churg
Journal:  JAMA       Date:  1968-04-08       Impact factor: 56.272

5.  Epidemiology of primary malignant mesothelial tumors in Canada.

Authors:  A D McDonald; A Harper; J C McDonald; O A el-Attar
Journal:  Cancer       Date:  1970-10       Impact factor: 6.860

6.  Epidemiology of mesothelioma on Walcheren Island.

Authors:  J Stumphius
Journal:  Br J Ind Med       Date:  1971-01

7.  Mortality from lung cancer and other causes among workers in an asbestos textile factory.

Authors:  J F Knox; S Holmes; R Doll; I D Hill
Journal:  Br J Ind Med       Date:  1968-10

8.  Mesothelioma of pleura and peritoneum following exposure to asbestos in the London area.

Authors:  M L Newhouse; H Thompson
Journal:  Br J Ind Med       Date:  1965-10

9.  Asbestosis and neoplastic disorders of the hematopoietic system.

Authors:  M A Gerber
Journal:  Am J Clin Pathol       Date:  1970-02       Impact factor: 2.493

10.  Effects of asbestos in dockyard workers.

Authors:  G Sheers; A R Templeton
Journal:  Br Med J       Date:  1968-09-07
View more
  6 in total

Review 1.  Does asbestos exposure cause gastrointestinal cancer?

Authors:  D S Levine
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

2.  Asbestos-Induced Gastrointestinal Cancer: An Update.

Authors:  Seok Jo Kim; David Williams; Paul Cheresh; David W Kamp
Journal:  J Gastrointest Dig Syst       Date:  2013-09-10

3.  Mortality in lung and gastrointestinal cancer among shipyard workers.

Authors:  A Sandén; P E Näslund; B Järvholm
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

Review 4.  Laryngeal cancer and occupational exposure to asbestos.

Authors:  D A Edelman
Journal:  Int Arch Occup Environ Health       Date:  1989       Impact factor: 3.015

Review 5.  Nonpulmonary outcomes of asbestos exposure.

Authors:  Melisa Bunderson-Schelvan; Jean C Pfau; Robert Crouch; Andrij Holian
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

6.  Risk assessment of gastric cancer associated with asbestosis: a case report.

Authors:  Soo-Hong Park; Dong-Mug Kang; Bon-Hak Koo; Young-Ki Kim; Jong-Eun Kim
Journal:  Ann Occup Environ Med       Date:  2015-03-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.